Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
GeneDx Holdings Corp. entered into Subscription Agreements with Corvex Select Equity Master Fund LP, Corvex Master Fund LP, Corvex Dynamic Equity Select Master Fund LP valued at Registered direct offering of 100,000,000 shares of Class A common stock; includes 77,663,376 shares (effective 2023-01-26).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Corvex Select Equity Master Fund LP, Corvex Master Fund LP, Corvex Dynamic Equity Select Master Fund LP
- Value
- Registered direct offering of 100,000,000 shares of Class A common stock; includes 77,663,376 shares
- Effective
- 2023-01-26
Exact text from the filing
(ii) subscription agreements (the “Subscription Agreements”) with Corvex Select Equity Master Fund LP, Corvex Master Fund LP and Corvex Dynamic Equity Select Master Fund LP, which are institutional investors affiliated with Keith Meister, a member of the Company’s board of directors, relating to a registered direct offering (the “Direct Offering” and, together with the Underwritten Offering, the “Offerings”) of 100,000,000 shares of Class A common stock comprising (A) 77,663,376 shares (the “Initial Direct Offering Shares”) that are expected to be issued following the closing of the Underwritten Offering and (B) 22,336,624 shares (the “Additional Direct Offering Shares”) that are subject to stockholder approval to satisfy Nasdaq Stock Market rules with respect to the issuance of such shares.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.95
GeneDx Holdings Corp. entered into Underwriting Agreement with Jefferies LLC valued at Underwritten public offering of 328,571,429 shares of Class A common stock at $0.35 per share; under (effective 2023-01-26).
- Action
- entry
- Agreement
- underwriting
- Counterparty
- Jefferies LLC
- Value
- Underwritten public offering of 328,571,429 shares of Class A common stock at $0.35 per share; under
- Effective
- 2023-01-26
Exact text from the filing
On January 26, 2023, GeneDx Holdings Corp. (the “Company”) entered into the following agreements in connection with offerings of an aggregate of 428,571,429 shares (the “Shares”) of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), at an offering price of $0.35 per share: (i) an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, the underwriter and sole book-running manager (the “Underwriter”), relating to an underwritten public offering (the “Underwritten Offering”) of 328,571,429 shares of Class A common stock
View on SEC.gov